Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples